Relievant Medsystems
Minneapolis
About Relievant Medsystems
Relievant provides patients with low-risk therapy that affords the ability to alleviate their back pain. The company's Relievant’s Intracept System delivers targeted energy into the spine and blocks the transmission of pain signals from the basivertebral nerve.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $273.6M
- Funding stage: M&A
- Last round: Series G (Mar 2023)
- Website: relievant.com
- Phone: 650-368-1000
Industries & Categories
Biotechnology, Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/relievant-medsystems-43623 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.